About NVision Imaging Technologies
NVision Imaging Technologies is a German MedTech company and University of Ulm spinoff that develops quantum-based hyperpolarization technology to enhance standard MRI systems for metabolic imaging. Their POLARIS platform hyperpolarizes carbon-13-labeled biomolecules to enable non-invasive, real-time assessment of human and animal metabolism, supporting early cancer diagnosis and treatment monitoring. The company serves preclinical and clinical research markets as well as clinical applications in oncology, cardiology, and nephrology.
Company details
Funding
Total raised
$93.8M
Last stage
Series A
Investors
Founders
Ilai Schwartz
Co-Founder and Chief Technology Officer of NVision Imaging Technologies.
Alex Retzker
Co-Founder of NVision Imaging Technologies.
Fedor Jelezko
Co-Founder of NVision Imaging Technologies.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.